These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10539807)

  • 1. Concern for azotemia with angiotensin-converting enzyme inhibitors: public health implications and clinical relevance.
    Bart BA
    Am Heart J; 1999 Nov; 138(5 Pt 1):801-3. PubMed ID: 10539807
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD).
    Knight EL; Glynn RJ; McIntyre KM; Mogun H; Avorn J
    Am Heart J; 1999 Nov; 138(5 Pt 1):849-55. PubMed ID: 10539815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). SOLVD Investigators.
    Kostis JB; Shelton B; Gosselin G; Goulet C; Hood WB; Kohn RM; Kubo SH; Schron E; Weiss MB; Willis PW; Young JB; Probstfield J
    Am Heart J; 1996 Feb; 131(2):350-5. PubMed ID: 8579032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction.
    Testani JM; Kimmel SE; Dries DL; Coca SG
    Circ Heart Fail; 2011 Nov; 4(6):685-91. PubMed ID: 21903907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of enalapril on renal function in patients with severe chronic kidney disease.
    Vernaglione L
    Nephrol Dial Transplant; 2007 Feb; 22(2):665-6. PubMed ID: 16951420
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal effects of angiotensin converting enzyme inhibitors in heart failure: a clinician's guide to minimizing azotemia and diuretic-induced electrolyte imbalances.
    Weinberg MS
    Clin Ther; 1993; 15(1):3-17; discussion 2. PubMed ID: 8458051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lisinopril and renal failure.
    Heeg JE; de Jong PE; de Zeeuw D
    Lancet; 1989 Apr; 1(8642):846. PubMed ID: 2564931
    [No Abstract]   [Full Text] [Related]  

  • 8. Why and when should we worry about worsening renal function?
    Damman K; McMurray JJ
    Eur J Heart Fail; 2014 Jan; 16(1):4-5. PubMed ID: 24453094
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin converting enzyme inhibitor-induced renal dysfunction: recommendations for prevention.
    Cooke HM; De Besse A
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):65-70. PubMed ID: 8004361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal function and heart failure treatment: when is a loss really a gain?
    Konstam MA
    Circ Heart Fail; 2011 Nov; 4(6):677-9. PubMed ID: 22086828
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of chronic kidney disease and anemia on hospitalization expense in patients with left ventricular dysfunction.
    Gregory DD; Sarnak MJ; Konstam MA; Pereira B; Salem D
    Am J Cardiol; 2003 Dec; 92(11):1300-5. PubMed ID: 14636907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy with ACE inhibitors in chronic heart failure and limited kidney function].
    Osterziel KJ; Nagel F; Dietz R
    Z Kardiol; 1994; 83 Suppl 4():81-7. PubMed ID: 7856286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin converting enzyme inhibition and chronic cyclosporine-induced renal dysfunction in type 1 diabetes.
    Hannedouche TP; Natov S; Boitard C; Lacour B; Grünfeld JP
    Nephrol Dial Transplant; 1996 Apr; 11(4):673-8. PubMed ID: 8671857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Losartan-induced azotemia in a diabetic recipient of a kidney transplant.
    Cohen LS; Friedman EA
    N Engl J Med; 1996 May; 334(19):1271-2. PubMed ID: 8606734
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction.
    Ishani A; Weinhandl E; Zhao Z; Gilbertson DT; Collins AJ; Yusuf S; Herzog CA
    J Am Coll Cardiol; 2005 Feb; 45(3):391-9. PubMed ID: 15680718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.
    Barnett AH; Bain SC; Bouter P; Karlberg B; Madsbad S; Jervell J; Mustonen J;
    N Engl J Med; 2004 Nov; 351(19):1952-61. PubMed ID: 15516696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progressive azotemia provoked by ACE inhibitor in renal ischemia].
    Fomin VV; Taronishvili OI; Shvetsov MIu; Shilov EM; Moiseev SV; Kushnir VV; Sorokin IuD
    Ter Arkh; 2004; 76(9):66-70. PubMed ID: 15532381
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter by Hammoud et al regarding article "Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition".
    Hammoud R; Vaccari CS; Khan BV
    Circulation; 2007 Jun; 115(24):e637; author reply e638. PubMed ID: 17576877
    [No Abstract]   [Full Text] [Related]  

  • 19. [Kidney insufficiency following use of enalapril for congestive heart failure].
    Schipperheyn JJ
    Ned Tijdschr Geneeskd; 1987 Sep; 131(39):1730-1. PubMed ID: 2823153
    [No Abstract]   [Full Text] [Related]  

  • 20. [Detail study of angiotensin-receptor blockade versus ACE-inhibition in type 2 diabetes with nephropathy].
    Nitschmann S; Girndt M; Köhler H
    Internist (Berl); 2005 Aug; 46(8):923-4, 926. PubMed ID: 15990988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.